How CTI Discovers Hidden Site Opportunities

In clinical research, trial planning can feel like piecing together a jigsaw puzzle where the pieces are scattered across countless databases and public records. This fragmentation creates costly delays, and missed opportunities to engage the right sites and investigators.

For Earl Seltzer, who leads strategy and innovation at CTI Clinical Trial and Consulting Services, he needed a way to understand exactly where the investigators were treating their target population without the labor-intensive manual searches.

In this conversation, Earl shares how CTI uses H1 to support his feasibility assessments, identify and expand site networks, and map patient journeys.

"The real benefit of H1 is the ability to bring a lot of these assets together into one place. And while we recognize that there are ways to acquire real-world data…we really felt it was necessary to invest in a subscription that would give us access to a wider swath of the claims data landscape."
-Earl Seltzer, Exec. Dir., Therapeutic Strategy & Innovation, CTI

Watch the interview to see how H1 helps CTI identify new clinicians and execute studies more efficiently. Request a demo to see how H1 for Clinical can help you identify sites with relevant trial experience globally.